BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (DRUG)

CUSIP: 10919W405

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 6 signals
Share change
+4,644,772
SEC-reported price per share
$36.02
Number of holders
31
Value change
+$167,324,812
Number of buys
25
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
10,194,635

Security key

10919W405

Report period

Q4 2024

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - COMMON STOCK, WITHOUT PAR VALUE (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ian McDonald
Disclosed value leader
Ian McDonald
Comparable rows
8/8
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 14% 13D/G row: Ian McDonald Showing 1-6 of 8 holder rows.

Quick read

Ian McDonald leads the comparable SEC ownership view at 14%.

8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ian McDonald's linked filing trail.
Comparable ownership Top 5
Ian McDonald 14%
Point72 Asset Management, L.P. 3%
AdvisorShares Investments LLC 1.8%
NATIONAL BANK OF CANADA /FI/ 0.05%
UBS Group AG 0.03%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 8 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ian McDonald
13D/G
14%
$85,992,664
1,396,665 shares
$0 04 Nov 2024
Point72 Asset Management, L.P.
13D/G
3%
$4,175,988
135,189 shares
$0 31 Dec 2024
AdvisorShares Investments LLC
13F
Company
13F
1.8%
$218,904
182,420 shares
30 Sep 2024
NATIONAL BANK OF CANADA /FI/
13F
Company
13F
0.05%
$5,802
4,959 shares
30 Sep 2024
UBS Group AG
13F
Company
13F
0.03%
$3,986
3,407 shares
30 Sep 2024
ROYAL BANK OF CANADA
13F
Company
13F
0.01%
$1,000
660 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
4,897,032
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q1 2026 Across Filers

Q1 2026 holders
94
Q4 2024 holders
31
Holder diff
-63
Investor Q1 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q1 2026 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .